Plasma VEGF levels in AMI were 5.1-fold higher than those of controls, and 2.8-fold higher than those of CAD patients (Control vs CAD/AMI, 16.04±12.05 vs 29.93±27.02/82.58±32.38 pg/mL, PControl vs CAD > 0.05, PControl vs AMI < 0.01, PCAD vs AMI < 0.01) (Fig. 1C). This evidence concerns the gene VEGFA and coronary artery disorder.